Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000411588

Medchemexpress LLC Oxolamine citrate | 1949-20-8 | MFCD00083457 | 99.9% | 500 MG
SDP

Supplier:  Medchemexpress LLC HYB1042500MG

Encompass_Preferred

Oxolamine citrate is an orally active antitussive that can inhibit CYP2B1/2. It exhibits anti-inflammatory effects on the respiratory organs. This product increases the AUC of Warfarin and prolongs its terminal half-life. It is intended for use in respiratory disease research.

  • Inhibits CYP2B1/2
  • Exhibits anti-inflammatory effects on respiratory organs
  • Increases the AUC of Warfarin
  • Prolongs Warfarin's terminal half-life
  • Reduces plasma protein binding of Clarithromycin in fresh rat plasma
  • Protects pulmonary parenchyma from emphysema in animal models

Catalog No. 50-004-11588


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.